HEB - Hemispherx Biopharma, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 517.86M
Enterprise Value 314.86M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)44.32
Price/Book (mrq)1.53
Enterprise Value/Revenue 336.87
Enterprise Value/EBITDA 6-1.19

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-3,331.02%

Management Effectiveness

Return on Assets (ttm)-46.22%
Return on Equity (ttm)-55.78%

Income Statement

Revenue (ttm)403k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)309.10%
Gross Profit (ttm)-1.02M
EBITDA -12.45M
Net Income Avi to Common (ttm)-7.44M
Diluted EPS (ttm)-0.2780
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.3M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)1.47M
Total Debt/Equity (mrq)14.60
Current Ratio (mrq)1.70
Book Value Per Share (mrq)0.32

Cash Flow Statement

Operating Cash Flow (ttm)-9.28M
Levered Free Cash Flow (ttm)-7.5M

Trading Information

Stock Price History

Beta -0.00
52-Week Change 3-12.42%
S&P500 52-Week Change 315.75%
52 Week High 30.8400
52 Week Low 30.3000
50-Day Moving Average 30.4776
200-Day Moving Average 30.3879

Share Statistics

Avg Vol (3 month) 3733.83k
Avg Vol (10 day) 3327.51k
Shares Outstanding 536.14M
Float 31.19M
% Held by Insiders 11.80%
% Held by Institutions 110.74%
Shares Short 31.13M
Short Ratio 36.47
Short % of Float 33.96%
Shares Short (prior month) 31.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3Aug 29, 2016